Potential effect of NICE tuberculosis guidelines on paediatric tuberculosis screening

Archives of Disease in Childhood

Volumn 93, Issue 3, 2008, Pages 200-203

  Taylor, R E B ^a   Cant, A J ^b   Clark, J E ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ARTICLE; CHEMOPROPHYLAXIS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; HEALTH CARE ORGANIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; SCREENING; TUBERCULIN TEST; TUBERCULOSIS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; MASS SCREENING; METHODOLOGY; PRESCHOOL CHILD; UNITED KINGDOM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; INTERFERON TYPE II; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; TUBERCULIN TEST; TUBERCULOSIS;

EID: 41749090306     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.106617     Document Type: Article

References (14)

1. NICE Guidelines. CG33 Tuberculosis: Full Guideline. 22 March 2006. http:// www.nice.org.uk/page.aspx?o = 297929
2. Joint Tuberculosis Committee of the British Thoracic Society. Control and Prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Thorax 2000;55:887-901.
3. Pai M, Riley LW, Colford JMJ. Interferon gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761-76.
4. Mazurek, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740-7.
5. Liebeschuetz S, et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004;364:2196-203.
6. Ewer K, et al. Comparison of T cell based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168- 73.
7. Lalvani A, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen specific T cells. Lancet 2001;357:2017-21.
8. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005;172:631-5.
9. Connell TG, Curtis N, Ranganathan SC, et al. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006;61:616-20.
10. Ferrara G, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006;367:1328-34.
11. Rose DN, Schechter CB, Adler JJ. Interpretation of the tuberculin skin test. J Gen Intern Med 1995;10:635-642.
12. Kang YA, et al. Discrepancy between the tuberculin skin test and the whole blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis burden country. JAMA 2005;293:2785-27.
13. Hill PC, et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 2006;117(5):1542-8.
14. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47.